Chapter title |
Biobanking of Human Mesenchymal Stem Cells: Future Strategy to Facilitate Clinical Applications
|
---|---|
Chapter number | 8 |
Book title |
Biobanking and Cryopreservation of Stem Cells
|
Published in |
Advances in experimental medicine and biology, November 2016
|
DOI | 10.1007/978-3-319-45457-3_8 |
Pubmed ID | |
Book ISBNs |
978-3-31-945455-9, 978-3-31-945457-3
|
Authors |
Kar Wey Yong, Jane Ru Choi, Wan Kamarul Zaman Wan Safwani, Yong, Kar Wey, Choi, Jane Ru, Wan Safwani, Wan Kamarul Zaman |
Editors |
Feridoun Karimi-Busheri, Michael Weinfeld |
Abstract |
Human mesenchymal stem cells (hMSCs), a type of adult stem cells that hold great potential in clinical applications (e.g., regenerative medicine and cell-based therapy) due to their ability to differentiate into multiple types of specialized cells and secrete soluble factors which can initiate tissue repair and regulate immune response. hMSCs need to be expanded in vitro or cryopreserved to obtain sufficient cell numbers required for clinical applications. However, long-term in vitro culture-expanded hMSCs may raise some biosafety concerns (e.g., chromosomal abnormality and malignant transformation) and compromised functional properties, limiting their use in clinical applications. To avoid those adverse effects, it is essential to cryopreserve hMSCs at early passage and pool them for off-the-shelf use in clinical applications. However, the existing cryopreservation methods for hMSCs have some notable limitations. To address these limitations, several approaches have to be taken in order to produce healthy and efficacious cryopreserved hMSCs for clinical trials, which remains challenging to date. Therefore, a noteworthy amount of resources has been utilized in research in optimization of the cryopreservation methods, development of freezing devices, and formulation of cryopreservation media to ensure that hMSCs maintain their therapeutic characteristics without raising biosafety concerns following cryopreservation. Biobanking of hMSCs would be a crucial strategy to facilitate clinical applications in the future. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 8% |
United States | 1 | 8% |
Unknown | 10 | 83% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 92% |
Scientists | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 22% |
Researcher | 8 | 22% |
Student > Ph. D. Student | 6 | 17% |
Student > Master | 2 | 6% |
Unspecified | 1 | 3% |
Other | 0 | 0% |
Unknown | 11 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 17% |
Agricultural and Biological Sciences | 5 | 14% |
Medicine and Dentistry | 3 | 8% |
Engineering | 2 | 6% |
Nursing and Health Professions | 1 | 3% |
Other | 6 | 17% |
Unknown | 13 | 36% |